Similar articles for PMID: 29970569

Year	Number of Results
1881	1
1957	1
1959	1
1967	1
1982	1
1991	2
1992	1
1993	2
1994	2
1996	1
1998	3
1999	4
2000	2
2001	2
2002	2
2003	3
2004	4
2005	3
2006	2
2007	3
2008	5
2009	5
2010	4
2011	8
2012	8
2013	6
2014	7
2015	9
2016	10
2017	12
2018	6
2019	9
2020	6
2021	2

1

Possible Application of Ascites-infiltrating Gamma-delta T Cells for Adoptive Immunotherapy.

Abe Y, Kobayashi H, Akizawa Y, Ishitani K, Hashimoto K, Matsui H. Abe Y, et al. Anticancer Res. 2018 Jul;38(7):4327-4331. doi: 10.21873/anticanres.12732. Anticancer Res. 2018. PMID: 29970569

2

Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.

Nagamine I, Yamaguchi Y, Ohara M, Ikeda T, Okada M. Nagamine I, et al. Hiroshima J Med Sci. 2009 Mar;58(1):37-44. Hiroshima J Med Sci. 2009. PMID: 19400555

3

Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.

Rong L, Li K, Li R, Liu HM, Sun R, Liu XY. Rong L, et al. World J Gastroenterol. 2016 Apr 7;22(13):3573-80. doi: 10.3748/wjg.v22.i13.3573. World J Gastroenterol. 2016. PMID: 27053849 Free PMC article.

4

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.

Cordova A, Toia F, La Mendola C, Orlando V, Meraviglia S, Rinaldi G, Todaro M, Cicero G, Zichichi L, Donni PL, Caccamo N, Stassi G, Dieli F, Moschella F. Cordova A, et al. PLoS One. 2012;7(11):e49878. doi: 10.1371/journal.pone.0049878. Epub 2012 Nov 26. PLoS One. 2012. PMID: 23189169 Free PMC article.

5

Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumors.

Oberg HH, Janitschke L, Sulaj V, Weimer J, Gonnermann D, Hedemann N, Arnold N, Kabelitz D, Peipp M, Bauerschlag D, Wesch D. Oberg HH, et al. J Leukoc Biol. 2020 Jun;107(6):1081-1095. doi: 10.1002/JLB.5MA1119-265R. Epub 2019 Dec 13. J Leukoc Biol. 2020. PMID: 31833593 Free PMC article.

6

Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma.

Kobayashi H, Tanaka Y, Yagi J, Minato N, Tanabe K. Kobayashi H, et al. Cancer Immunol Immunother. 2011 Aug;60(8):1075-84. doi: 10.1007/s00262-011-1021-7. Epub 2011 Apr 26. Cancer Immunol Immunother. 2011. PMID: 21519826 Clinical Trial.

7

Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.

Murayama M, Tanaka Y, Yagi J, Uchiyama T, Ogawa K. Murayama M, et al. Anticancer Res. 2008 Sep-Oct;28(5B):2921-31. Anticancer Res. 2008. PMID: 19031935 Free article.

8

Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer.

Wada I, Matsushita H, Noji S, Mori K, Yamashita H, Nomura S, Shimizu N, Seto Y, Kakimi K. Wada I, et al. Cancer Med. 2014 Apr;3(2):362-75. doi: 10.1002/cam4.196. Epub 2014 Feb 7. Cancer Med. 2014. PMID: 24515916 Free PMC article. Clinical Trial.

9

Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.

Zhou J, Kang N, Cui L, Ba D, He W. Zhou J, et al. Cell Mol Immunol. 2012 Jan;9(1):34-44. doi: 10.1038/cmi.2011.16. Epub 2011 Jun 13. Cell Mol Immunol. 2012. PMID: 21666706 Free PMC article. Clinical Trial.

10

γδ T cells in cancer immunotherapy.

Zou C, Zhao P, Xiao Z, Han X, Fu F, Fu L. Zou C, et al. Oncotarget. 2017 Jan 31;8(5):8900-8909. doi: 10.18632/oncotarget.13051. Oncotarget. 2017. PMID: 27823972 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed